|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
ATE102631T1
(de)
|
1988-11-11 |
1994-03-15 |
Medical Res Council |
Klonierung von immunglobulin sequenzen aus den variabelen domaenen.
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US6291158B1
(en)
|
1989-05-16 |
2001-09-18 |
Scripps Research Institute |
Method for tapping the immunological repertoire
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
WO1993011236A1
(en)
|
1991-12-02 |
1993-06-10 |
Medical Research Council |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
|
|
PT1589107E
(pt)
|
1992-08-21 |
2010-03-29 |
Univ Bruxelles |
Imunoglobulinas desprovidas de cadeias leves
|
|
US20080152586A1
(en)
|
1992-09-25 |
2008-06-26 |
Avipep Pty Limited |
High avidity polyvalent and polyspecific reagents
|
|
EP1550729B1
(en)
|
1992-09-25 |
2009-05-27 |
Avipep Pty Limited |
Target binding polypeptide comprising an IG-like VL domain linked to an IG-like VH domain
|
|
EP0627932B1
(en)
|
1992-11-04 |
2002-05-08 |
City Of Hope |
Antibody construct
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
US5928939A
(en)
*
|
1995-03-01 |
1999-07-27 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor-b and dna coding therefor
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US6113898A
(en)
|
1995-06-07 |
2000-09-05 |
Idec Pharmaceuticals Corporation |
Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
|
|
EP0859841B1
(en)
|
1995-08-18 |
2002-06-19 |
MorphoSys AG |
Protein/(poly)peptide libraries
|
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
|
AU740043B2
(en)
|
1996-06-27 |
2001-10-25 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Recognition molecules interacting specifically with the active site or cleft of a target molecule
|
|
DE19742706B4
(de)
|
1997-09-26 |
2013-07-25 |
Pieris Proteolab Ag |
Lipocalinmuteine
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP221098A0
(en)
|
1998-03-06 |
1998-04-02 |
Diatech Pty Ltd |
V-like domain binding molecules
|
|
CA2323726C
(en)
|
1998-03-20 |
2005-02-08 |
Benitec Australia Ltd. |
Control of gene expression
|
|
DK1068311T3
(da)
|
1998-04-08 |
2011-08-08 |
Commw Scient Ind Res Org |
Fremgangsmåder og midler til opnåelse af modificerede fænotyper
|
|
ATE352559T1
(de)
|
1998-12-08 |
2007-02-15 |
Biovation Ltd |
Verfahren zur verminderung der immunogenität von proteinen
|
|
US7115396B2
(en)
|
1998-12-10 |
2006-10-03 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
US7270969B2
(en)
|
1999-05-05 |
2007-09-18 |
Phylogica Limited |
Methods of constructing and screening diverse expression libraries
|
|
US6326193B1
(en)
|
1999-11-05 |
2001-12-04 |
Cambria Biosciences, Llc |
Insect control agent
|
|
AU2002218166A1
(en)
|
2000-09-08 |
2002-03-22 |
Universitat Zurich |
Collections of repeat proteins comprising repeat modules
|
|
WO2002088171A2
(en)
|
2001-04-26 |
2002-11-07 |
Avidia Research Institute |
Combinatorial libraries of monomer domains
|
|
CN1671416B
(zh)
|
2001-07-12 |
2013-01-02 |
杰斐逊·富特 |
超人源化抗体
|
|
DE60310383T2
(de)
*
|
2002-01-29 |
2007-09-20 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
Vorbeugung von gewebeadhäsion
|
|
CA2429483A1
(en)
|
2002-05-17 |
2003-11-17 |
Amrad Operations Pty Ltd. |
Immunointeractive molecules
|
|
US20030232439A1
(en)
|
2002-06-17 |
2003-12-18 |
Isis Pharmaceuticals Inc. |
Antisense modulation of VEGF-B expression
|
|
US7217798B2
(en)
|
2003-10-15 |
2007-05-15 |
Pdl Biopharma, Inc. |
Alteration of Fc-fusion protein serum half-lives by mutagenesis
|
|
US7217797B2
(en)
|
2002-10-15 |
2007-05-15 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
CA2512729C
(en)
|
2003-01-09 |
2014-09-16 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
|
CN1822857A
(zh)
|
2003-06-02 |
2006-08-23 |
阿莱克申药物公司 |
去免疫原性抗cd3抗体
|
|
ATE416190T1
(de)
|
2003-07-04 |
2008-12-15 |
Affibody Ab |
Polypeptide mit bindungsaffinität für her2
|
|
AU2003275958A1
(en)
|
2003-08-25 |
2005-03-10 |
Pieris Proteolab Ag |
Muteins of tear lipocalin
|
|
BRPI0417302A
(pt)
|
2003-12-05 |
2007-03-06 |
Compound Therapeutics Inc |
inibidores de receptores de fator de crescimento endotelial vascular do tipo 2
|
|
US20050282233A1
(en)
*
|
2004-03-05 |
2005-12-22 |
Ludwig Institute For Cancer Research |
Multivalent antibody materials and methods for VEGF/PDGF family of growth factors
|
|
DK1751181T3
(da)
|
2004-06-02 |
2012-11-26 |
Adalta Pty Ltd |
BINDINGSDELE, DER ER BASERET PÅ HAJ IgNAR-DOMÆNER
|
|
ES2456943T3
(es)
|
2004-08-02 |
2014-04-24 |
Zenyth Operations Pty. Ltd. |
Método de tratamiento de cáncer que comprende un antagonista de VEGF-B
|
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
AU2006281980A1
(en)
|
2005-08-15 |
2007-02-22 |
Cephalon Australia Pty Ltd |
Engineered antibodies with new world primate framework regions
|
|
WO2007140534A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Csl Limited |
Vegf-a cross-reactive anti- vegf-b antibodies as antagonists of vegf-a and vegf-b signalling
|
|
NZ579107A
(en)
*
|
2007-02-19 |
2012-05-25 |
Marinepolymer Tech Inc |
Poly-beta-1-4-n-acetylglucosamine hemostatic compositions and therapeutic regimens
|
|
WO2009045356A2
(en)
*
|
2007-09-28 |
2009-04-09 |
Yale University |
Microrna compositions in the treatment of vegf-mediated disorders
|
|
US20110150900A1
(en)
*
|
2008-04-09 |
2011-06-23 |
Ludwig Institute For Cancer Research |
Regulation of fatty acid transporters
|
|
CN102076844B
(zh)
*
|
2008-06-30 |
2013-08-07 |
成血管细胞系统公司 |
采用组合疗法的眼病和过度血管新生的治疗
|
|
RU2395521C1
(ru)
*
|
2008-11-10 |
2010-07-27 |
Учреждение Российской Академии Наук Институт Биологии Гена Ран |
Наноантитело v9, связывающее vegf, и способ его получения, кодирующая v9 нуклеотидная последовательность и содержащий ее вектор, способ ингибирования пролиферации эндотелиальных клеток
|
|
MX348166B
(es)
|
2008-12-19 |
2017-06-01 |
Macrogenics Inc |
Diacuerpos covalentes y sus usos.
|
|
US9259507B2
(en)
*
|
2009-04-21 |
2016-02-16 |
Warsaw Orthopedic, Inc. |
Tissue augmentation with active agent for wound healing
|
|
EP2367000A1
(en)
|
2010-03-04 |
2011-09-21 |
Charité Universitätsmedizin Berlin |
High throughput analysis of T-cell receptor repertoires
|